Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000958385 | SCV001105222 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000958385 | SCV001793712 | likely benign | not provided | 2021-01-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000958385 | SCV004135909 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | DCHS1: BP4 |
Breakthrough Genomics, |
RCV000958385 | SCV005221268 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000958385 | SCV001798556 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000958385 | SCV001965196 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003985469 | SCV004756606 | likely benign | DCHS1-related disorder | 2022-10-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |